课题基金 / 基金详情

DNA Deformations and Interactions with Proteins

DNA Deformations and Interactions with Proteins
DNA 变形和与蛋白质的相互作用
批准号:
7048215
负责人:
ROBERT L JERNIGAN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

ROBERT L JERNIGAN的其他基金

相似基金

相关文献

中文摘要
翻译
我们报告了几个与DNA序列依赖性结构特征相关的具体项目,这些结构特征对与蛋白质(包括细菌gal-阻遏物和人p53)的相互作用、基因组DNA的高阶自组织和基因调控至关重要。 1.原核生物中的DNA环 多亚基蛋白质-DNA复合物的稳定化通过DNA成环来促进。最好的特征之一是大肠杆菌中的gal环。大肠杆菌,参与gal操纵子的调控。为了确定DNA环在这种复杂结构中的最佳轨迹,我们使用了适合大规模DNA模拟的基于知识的弹性模型(由我们早期开发)。结果,我们发现,“反平行”的半乳糖环是积极的比“平行”的一个更有利。在乳糖阻遏物与DNA结合后形成的DNA环中也发现了相同的趋势。 基于这些计算,我们设计了详细的实验来可视化细菌中DNA环的3D组织。原子力显微镜支持"反平行" DNA环,无论是与gal和lac阻遏物。 这些结果表明,“反平行”的DNA环可能是浓缩的细菌类核的一般特征,而不是平行的DNA“包装”周围的组蛋白在真核细胞染色质。重要的是,原核生物中规则的DNA折叠与细菌基因组中弯曲的A束的周期性分布一致,如下所述。 2.原核生物和真核生物中A束和G束的分布及DNA包装 DNA中A和G束的周期性定位导致溶液中的DNA弯曲,并促进其在与蛋白质的复合物中的弯曲。在这里,我们分析了这些序列在原核和真核基因组中的分布。 我们发现,在原核生物基因组中的强弯曲的A-束(4 - 7 bp)的分布表现出显着的10 - 11 bp的周期性。这种周期性可能反映了原核DNA形成环状结构的内在倾向。根据这些数据,并通过与大肠杆菌中的"基因阻遏"半乳糖环和乳糖环的类比,大肠杆菌中,我们推测100 bp结构周期的环状折叠可能是原核生物类核包装的基本单位。这一假设通过细菌类核的微球菌核酸酶消化进行了验证(与S. Adhya,NCI)。结果表明,100 bp的DNA片段在消化产物中高度过量,从而暗示了高度特异性的类核包装,DNA结构周期为100 bp。另一方面,G束在原核基因组中的代表性不足。 相比之下,所有长度的A-和G-束在真核生物基因组中都高度过度表达。然而,"最佳" A片段(4 - 7bp)没有显示10 - 11bp的周期性。显然,由A束引起的DNA的固有曲率不是核小体形成的必要先决条件。相反,在真核生物基因组中观察到的过度丰富的长嘌呤(A和G)运行可能作为“染色质组织者”,降低DNA形成核小体的倾向,特别是在启动子区域。我们目前正在研究CpG岛上的G-束聚类,特别是在癌症相关基因启动子附近。 3.人类DNA中p53位点的全基因组分布 与DNA结合的四聚体p53在肿瘤抑制中起关键作用。在DNA损伤和其他类型的细胞应激反应中,p53蛋白被激活并特异性结合DNA序列,作为转录因子或细胞周期调节因子发挥作用。p53在调节广泛的基因方面是独特的:成千上万的人类基因被p53激活或抑制。正常情况下,p53四聚体与DNA反应元件结合,DNA反应元件由两个十聚体RRRCWWGYYY(半位点)组成,由间隔区隔开。(The间隔区S的长度在已知的功能结合位点中从0到14 bp变化,但在大多数情况下S = 0或1。在人类基因组中,有多少个假定的p53结合位点与这个方案一致?垫片长度的分布情况如何? 有了人类基因组序列,我们可以直接回答这些问题。间隔区的分布证明在所有人类染色体中是极不均匀的,在谱中具有强峰,超过平均背景3 - 4倍。在S = 0和10 bp处的峰以及在4 - 5 bp处的差距与我们早期的计算机建模和电泳测量一致,表明p53核心结构域在DNA环外侧的横向定位。一般来说,这些数据同意的想法,p53四聚体可以结合DNA特异性,而不解开核小体的过程中的染色质组装基因的转录激活。 目前,我们正在探索本地化的假定p53位点相对于转录的开始。我们的数据表明,在基因附近的p53位点的分布方面,上调和下调基因之间存在很大差异。与下调基因相比,上调基因的特征在于在从转录开始的1 Kbp内p53位点的出现率高两倍。此外,下调的基因揭示了具有"不寻常的"间隔子S = 3的p53位点的较高分数,其较早地显示出抑制相应基因的转录。这些是非常重要的观察结果,因为它们可以用于预测p53激活和抑制基因。 总之,p53位点在人类基因组中的分布反映了p53结合及其肿瘤抑制功能的多功能性。
英文摘要
We report on several specific projects that are related to the DNA sequence-dependent structural characteristics, important for interactions with proteins (including bacterial gal-repressor and human p53), higher order self-organization of genomic DNA, and gene regulation. 1. DNA looping in prokaryotes Stabilization of the multi-subunit protein-DNA complexes is facilitated by DNA looping. One of the best characterized is the gal loop in E. coli, involved in regulation of the gal operon. To determine the optimal trajectory of the DNA loop in such a complex structure, we used the knowledge-based elastic model suitable for large-scale DNA simulations (developed by us earlier). As a result, we found that the "antiparallel" gal loop is energetically more favorable than the "parallel" one. The same trend was found for the DNA loop formed upon binding of the lac repressors to DNA. Based on these computations, we designed detailed experiments to visualize the 3D organization of the DNA loops in bacteria. The atomic force microscopy supports the "antiparallel" DNA looping, both with the gal and lac repressors. These results imply that the "antiparallel" DNA looping may be a general feature of the condensed bacterial nucleoid, as opposed to the parallel DNA "wrapping" around histones in eukaryotic chromatin. Importantly, the regular DNA folding in prokaryotes is consistent with the periodic distribution of the curved A-tracts in bacterial genomes, described below. 2. Distribution of A- and G-tracts and DNA packaging in pro- and eukaryotes Periodic positioning of the A- and G-tracts in DNA causes DNA curvature in solution and facilitates its bending in the complexes with proteins. Here, we analyzed distribution of these sequences in the pro- and eukaryotic genomes. We found that distribution of the strongly bent A-tracts (4-7 bp) in the prokaryotic genomes demonstrates a remarkable periodicity of 10-11 bp. Such a periodicity may reflect the intrinsic propensity of prokaryotic DNA to form the loop-shaped structures. Based on these data and by analogy with the "gene repression" gal- and lac-loops in E. coli, we hypothesize that the loop folds with the structural period of 100 bp may be elementary units of the prokaryotic nucleoid packaging. This hypothesis was tested by the micrococcal nuclease digestion of bacterial nucleoids (in collaboration with S. Adhya, NCI). The results show that the 100 bp DNA fragments are highly overrepresented in digestion products, thereby implying a highly specific nucleoid packaging, with the DNA structural period of 100 bp. On the other hand, the G-tracts are underrepresented in prokaryotic genomes. In contrast, both the A- and G-tracts of all lengths are highly overrepresented in eukaryotic genomes. However, the "optimal" A-tracts (4-7 bp) do not reveal the 10-11 bp periodicity. Apparently, the intrinsic curvature of DNA, caused by the A-tracts, is not a necessary prerequisite for the formation of nucleosomes. Rather, the overabundant long purine (A and G) runs observed in eukaryotic genomes may serve as the "chromatin organizers," decreasing the DNA propensity for the formation of nucleosomes, especially in the promoter regions. We are currently studying the G-tract clustering in the CpG islands, in particular in the vicinity of the cancer-related genes' promoters. 3. Genome-wide distribution of p53 sites in human DNA The tetrameric p53 binding to DNA plays a key role in tumor suppression. In response to DNA damage and other types of cellular stress, the p53 protein becomes activated and binds DNA sequence-specifically, functioning as a transcriptional factor or cell cycle regulator. p53 is unique in regulating a wide spectrum of genes: thousands of human genes are either activated or repressed by p53. Normally, the p53 tetramer binds to DNA response elements, consisting of two decamers RRRCWWGYYY (half-sites) separated by a spacer. (The length of the spacer, S, varies from 0 to 14 bp in the known functional binding sites, but in most cases S=0 or 1.) How many putative p53 binding sites, consistent with this scheme, are there in the human genome? What is the distribution of the spacer lengths? With the human genome sequence we can directly answer these questions. The distribution of spacers proves to be extremely nonuniform in all human chromosomes, with strong peaks in the profile, exceeding the average background 3-4 fold. The peaks at S=0 and 10 bp, and the gap at 4-5 bp are consistent with our earlier computer modeling and electrophoresis measurements, indicating the lateral positioning of the p53 core domains on the outer side of the DNA loop. In general, these data agree with the idea that the p53 tetramer can bind DNA specifically without unwrapping nucleosomes in the course of transcriptional activation of the chromatin-assembled genes. Currently, we are exploring localization of the putative p53 sites with respect to the starts of transcription. Our data indicate strong difference between the up- and down-regulated genes in terms of distribution of the p53 sites in the vicinity of genes. The up-regulated genes are characterized by a twofold higher occurrence of the p53 sites within 1 Kbp from the start of transcription, compared to the down-regulated genes. In addition, the down-regulated genes reveal a higher fraction of the p53 sites with "unusual" spacer S=3, shown earlier to repress transcription of the corresponding genes. These are extremely important observations, as they can be used for prediction of the p53-activated and repressed genes. Summarizing, distribution of p53 sites in the human genome reflects the versatility of p53 binding and its tumor suppressor functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Use of Genome Information to Understand Mutations
  • 批准号:
    10488281
  • 项目类别:
  • 资助金额:
    $46.39万
  • 财政年份:
    2021
  • 负责人:
    ROBERT L JERNIGAN
  • 依托单位:
Novel Use of Genome Information to Understand Mutations
  • 批准号:
    10303852
  • 项目类别:
  • 资助金额:
    $48.06万
  • 财政年份:
    2021
  • 负责人:
    ROBERT L JERNIGAN
  • 依托单位:
Novel Use of Genome Information to Understand Mutations
  • 批准号:
    10661834
  • 项目类别:
  • 资助金额:
    $46.5万
  • 财政年份:
    2021
  • 负责人:
    ROBERT L JERNIGAN
  • 依托单位:
Modeling Ribosomal Control, Function and Assembly
  • 批准号:
    7290378
  • 项目类别:
  • 资助金额:
    $25.14万
  • 财政年份:
    2006
  • 负责人:
    ROBERT L JERNIGAN
  • 依托单位:
海外基金